BERLIN, GERMANY--(Marketwire - February 29, 2012) -
MagForce AG /
MagForce AG Successfully Completes Capital Increase
Processed and transmitted by Thomson Reuters ONE. The issuer is solely
responsible for the content of this announcement.
Announcement in accordance with section 17 para. 2 of the General Terms
Conditions of Deutsche Börse AG for the Regulated Unofficial Market
Frankfurt Stock Exchange
Berlin, February 29, 2012 - MagForce AG (Frankfurt, XETRA: MF6), a
medical technology company focusing on nanomedicine in oncology has completed
share placement with institutional investors. All of the 825,408 newly
shares were placed, with profit participation rights dating from
1, 2011, at a price of EUR 5.50 per share. The gross proceeds from the
increase, in the amount of EUR 4,539,744.00 will be used for
commercialization activities and the clinical development of the
technology along with the expansion of commercial and strategic partnerships.
This transaction increases the nominal share capital of the company, from
4.127.041, divided into 4,127,041 shares with an imputed nominal value of
1.00, to EUR 4,952,495.00.
The very successful capital increase and the meetings with the
investors were managed by Silvia Quandt & Cie. AG as a tied agent as defined
§ 2 paragraph 10 of the Banking Act (KWG) and called on account of biw
Investments & Securities Ltd.
About MagForce AG:
MagForce AG is a leading medical technology company focusing on nanomedicine
oncology. The company's proprietary procedure, NanoTherm® therapy,
targeted treatment of solid tumors through the intratumoral generation of heat
via activation of magnetic nanoparticles. NanoTherm®, NanoPlan®, and
NanoActivator™ are components of the therapy and have received EU-wide
regulatory approval as medical devices for the treatment of brain tumors.
MagForce, NanoTherm, NanoPlan and NanoActivator are trademarks of MagForce AG
selected countries. For more information, please visit www.magforce.com.
This release may contain forward-looking statements and information which may
identified by formulations using terms such as "expects", "aims",
"intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-
looking statements are based on our current expectations and certain
assumptions, which may be subject to a variety of risks and uncertainties. The
results actually achieved by MagForce AG may substantially differ from these
forward-looking statements. MagForce AG assumes no obligation to update these
forward-looking statements or to correct them in case of developments, which
differ from those, anticipated.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: MagForce AG via Thomson Reuters ONE